Stromal tumor of uncertain malignant potential of the prostate.
Murer LM, Talmon GA.
Arch Pathol Lab Med. 2014 Nov;138(11):1542-5. doi: 10.5858/arpa.2013-0212-RS.
Integration Analysis of Single-Cell Multi-Omics Reveals Prostate Cancer Heterogeneity.
Bian X, Wang W, Abudurexiti M, Zhang X, Ma W, Shi G, Du L, Xu M, Wang X, Tan C, Sun H, He X, Zhang C, Zhu Y, Zhang M, Ye D, Wang J.
Adv Sci (Weinh). 2024 May;11(18):e2305724. doi: 10.1002/advs.202305724. Epub 2024 Mar 14.
A rare case of malignant solitary fibrous tumor in prostate with review of the literature.
Ronchi A, La Mantia E, Gigantino V, Perdonà S, De Sio M, Facchini G, Franco R, De Chiara A.
Diagn Pathol. 2017 Jul 7;12(1):50. doi: 10.1186/s13000-017-0640-5.
Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing.
Ma X, Guo J, Liu K, Chen L, Liu D, Dong S, Xia J, Long Q, Yue Y, Zhao P, Hu F, Xiao Z, Pan X, Xiao K, Cheng Z, Ke Z, Chen ZS, Zou C.
Mol Cancer. 2020 Oct 8;19(1):147. doi: 10.1186/s12943-020-01264-9.
Complexity of Neural Component of Tumor Microenvironment in Prostate Cancer.
Sejda A, Sigorski D, Gulczyński J, Wesołowski W, Kitlińska J, Iżycka-Świeszewska E.
Pathobiology. 2020;87(2):87-99. doi: 10.1159/000505437. Epub 2020 Feb 11.
18F-FDG PET/CT Imaging of Prostate Stromal Tumor of Uncertain Malignant Potential.
Fabio M, Alfredo B, Antonella C, Stefano P, Sergio B.
Clin Nucl Med. 2021 Apr 1;46(4):348-349. doi: 10.1097/RLU.0000000000003509.
Rapidly progressing malignant phyllodes tumor of the prostate with normal prostate-specific antigen levels: A case report.
Zhang X, Hu J, Xu X, Cheng L.
Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S50-S52. doi: 10.4103/IJPM.IJPM_427_18.
Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives.
Zong Y, Montironi R, Massari F, Jiang Z, Lopez-Beltran A, Wheeler TM, Scarpelli M, Santoni M, Cimadamore A, Cheng L.
Eur Urol Focus. 2021 Sep;7(5):955-963. doi: 10.1016/j.euf.2020.10.007. Epub 2020 Oct 31.
Malignant function of nuclear factor-kappaB axis in prostate cancer: Molecular interactions and regulation by non-coding RNAs.
Al-Rashidi RR, Noraldeen SAM, Kareem AK, Mahmoud AK, Kadhum WR, Ramírez-Coronel AA, Iswanto AH, Obaid RF, Jalil AT, Mustafa YF, Nabavi N, Wang Y, Wang L.
Pharmacol Res. 2023 Aug;194:106775. doi: 10.1016/j.phrs.2023.106775. Epub 2023 Apr 17.
Relevance of emerging metabolomics-based biomarkers of prostate cancer: a systematic review.
Bansal N, Kumar M, Sankhwar SN, Gupta A.
Expert Rev Mol Med. 2022 Jun 22;24:e25. doi: 10.1017/erm.2022.20.
